Request appointment
1240 S Cedar Crest BlvdSuite 401Allentown, PA 18103
Fax+1 610-402-7881
Overview of Dr. Palyca
Dr. Paul Palyca is an oncologist in Allentown, PA and is affiliated with multiple hospitals in the area, including Lehigh Valley Hospital-Cedar Crest, Thomas Jefferson University Hospital, and Lehigh Valley Health Network - Muhlenberg. He received his medical degree from Rutgers Robert Wood Johnson Medical School and has been in practice 17 years. He is one of 60 doctors at Lehigh Valley Hospital-Cedar Crest and one of 16 doctors at Lehigh Valley Health Network - Muhlenberg who specialize in Oncology. He has 6 publications and over 100 citings.
Education & Training
Rutgers Health/Robert Wood Johnson Medical SchoolFellowship, Hematology and Medical Oncology, 2012 - 2015- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Internal Medicine, 2009 - 2012
Rutgers Robert Wood Johnson Medical SchoolClass of 2009
Certifications & Licensure
PA State Medical License 2015 - 2026
NJ State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2016-2017
Publications & Presentations
PubMed
- Interprovider Variation in Initiation of Bone-Modifying Agents for Patients With Prostate Cancer.Aaron P Mitchell, Andrew Salner, Paul Palyca, Azeez Farooki, Sonia Persaud
JCO Oncology Practice. 2026-09-01 - 16 citationsNeoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort.Viranda H Jayalath, Melissa Assel, Gopa Iyer, Scot Niglio, Bernard H Bochner
European Urology. 2026-02-01 - 1 citationsA phase 1b/2 study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer and no mutations in DNA damage respon...Karen A Autio, Christos E Kyriakopoulos, Paul Palyca, Han Xiao, Hamid Emamekhoo
Investigational New Drugs. 2025-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: